| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,144 | 0,156 | 21.08. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.08. | Creo Medical Group - Holding(s) in Company | - | RNS | ||
| 28.07. | Creo Medical steigert Umsatz im ersten Halbjahr 2026 um 45 % | 1 | Investing.com Deutsch | ||
| 28.07. | Creo Medical Group - H1-26 Trading Update | - | RNS | ||
| 23.07. | Creo Medical meldet über 100 klinische Anwendungen für MicroBlate Flex | 2 | Investing.com Deutsch | ||
| 23.07. | Creo Medical's MicroBlate Flex surpasses 100 clinical cases | 2 | Investing.com | ||
| CREO MEDICAL Aktie jetzt für 0€ handeln | |||||
| 23.07. | Creo Medical Group - MicroBlate Flex exceeds 100 clinical cases | - | RNS | ||
| 06.07. | Creo Medical: Führungskräfte erwerben Aktien über Mitarbeiterbeteiligungsprogramm | 1 | Investing.com Deutsch | ||
| 06.07. | Creo Medical Group - Award of Shares under Share Incentive Plan | - | RNS | ||
| 29.06. | Creo Medical flags 60pc rise in first-quarter revenue | 1 | Sharecast | ||
| 29.06. | Creo Medical Group - Result of AGM | 1 | RNS | ||
| 29.06. | Creo Medical Group - AGM Statement | - | RNS | ||
| 23.06. | Creo Medical Group - Appointment of Nominated Adviser /Corporate Broker | - | RNS | ||
| 04.06. | Creo Medical Group - Posting of 2025 Annual Report and Notice of AGM | - | RNS | ||
| 28.05. | Creo Medical Group - Holding(s) in Company | - | RNS | ||
| 22.05. | Creo Medical raises £5.5m in share placing at premium | 1 | Investing.com | ||
| 22.05. | Creo Medical Group sees 50% surge in year-on-year revenues | 2 | The Armchair Trader | ||
| 22.05. | Creo Medical jumps as it plans GBP5.5 million placing, stake sale | 2 | Alliance News | ||
| 22.05. | Creo Medical Group - Result of Placing | 2 | RNS | ||
| 22.05. | WINNERS & LOSERS: Creo Medical jumps; Hercules resumes trading | 1 | Alliance News | ||
| 22.05. | Creo Medical explores sale of 49% stake in European unit | 1 | Investing.com |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HVIVO | 0,068 | +0,75 % | hVIVO PLC - H1 2026 Trading Update | ||
| FRESENIUS MEDICAL CARE | 40,140 | -1,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 46,600 | +0,83 % | PRESSESPIEGEL/Unternehmen: PORSCHE, FRANKFURTER LEBEN/DWS, FRESENIUS KABI, ANTHROPIC, LEGORA | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
PORSCHE - Der Sportwagenbauer Porsche plant nach Informationen der Wirtschaftswoche... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,200 | +0,98 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| HEARTFLOW | 49,750 | 0,00 % | Heartflow Aktie auf Rekordhoch: Kurs steigt auf 48,7 USD | ||
| LIFESTANCE HEALTH GROUP | 12,470 | -1,42 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,170 | 0,00 % | Biotech Stocks At 52-Week Highs - PARK +10%, AVAH +24%, CADL +10% On Q2 Reports, LH, COAG | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| PROGYNY | 25,650 | -1,19 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,84 | -1,16 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BILLIONTOONE | 95,20 | -0,07 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,480 | +1,06 % | Milliardenmarkt Augengesundheit: Warum EssilorLuxottica und Carl Zeiss Meditec auf neue Technologien setzen - und wo Rise Nano Optics ins Spiel kommt | ||
| GENEDX | 87,05 | +5,45 % | GeneDx launches online exome testing for pediatric patients | ||
| ALIGNMENT HEALTHCARE | 13,165 | 0,00 % | Alignment Healthcare files motion to dismiss whistleblower lawsuit | ||
| SANARA MEDTECH | 34,430 | +0,55 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,120 | -0,38 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |